ADR
Adherium Limited
🇦🇺 ASX
🩺 HEALTH CARE
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-16.00%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Adherium Ltd. engages in the development, manufacture, and supply of digital health technologies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-26. The firm is focused on patient medication adherence, remote monitoring and data management solutions for patients, payers and providers. The Company’s Hailie sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and chronic obstructive pulmonary disease (COPD), and reduces direct and indirect healthcare costs. The Company’s technologies include The Hailie Remote Patient Management (RPM) Solution, The Hailie Sensors and The Hailie Solution. Its Hailie solution is a cloud-based platform, which captures medication use data from Food and Drug Administration (FDA)-cleared Bluetooth enabled sensors, which wrap around patient inhalers and provide real-time feedback to patients via the Hailie application and to their physicians via the Hailie portal.
📈 Performance
Price History
-98.20%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.01
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ADR
0
📊 Total Capital Earnings
$492.80
🔃 Average investment frequency
23 weeks
💵 Average investment amount
$2,995
⏰ Last time a customer invested in ADR
48 days
ADR investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in ADR also invest in...
VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
🙌 Performance (5Yr p.a)
17.92%
📊 Share price
$427.61 AUD
📈 HIGH PRICE GROWTH
⛳️ DIVERSIFIED
🤖 TECHNOLOGY
Alcidion Group Ltd. engages in the development and provision of healthcare software products marketed under the Miya, Patientrack, Smartpage and ExtraMed brands. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. The firm's principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. The firm's other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users.
🙌 Performance (5Yr p.a)
-14.63%
📊 Share price
$0.05 AUD
🩺 HEALTH CARE
Anson Resources Ltd. is an exploration company, which engages in iron sand mining activities. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-07-08. The principal activity of the Company is exploration and evaluation of mineral licenses and process development primarily for the extraction of lithium, bromine, iodine and boron chemicals. Its projects include Paradox Lithium Project, Green River Lithium Project, Yellow Cat Uranium- Vanadium Project, and Western Australian Exploration Projects. The company also has a portfolio of three base metals and critical metals exploration projects covering a total of 458 square kilometers in the Yilgarn Craton of Western Australia, including Bull Nickel-Copper-PGE Project, The Ajana Project, and Hooley Well Cobalt-Nickel Laterite Project. The Paradox Basin Brine Project is located in southeastern Utah, USA, and encompasses a land position of over 21,450 hectares. Green River Lithium Project is located 50 kilometers northwest of the Company’s Paradox Lithium Project. The Yellow Cat Project is located in the Thompson District.
🙌 Performance (5Yr p.a)
23.75%
📊 Share price
$0.07 AUD
📈 HIGH PRICE GROWTH
⛏️ MINING
Appen Ltd. engages in the development of human-annotated datasets for machine learning and artificial intelligence. The company is headquartered in Chatswood, New South Wales and currently employs 992 full-time employees. The company went IPO on 2015-01-07. The firm is engaged in providing data services for deep learning and generative artificial intelligence (AI) systems. The firm operates through two segments: Global Services and New Markets. The Global Services represent the services that the Company provides to its five United States technology customers (Global customers) using the customer's data annotation platforms and tools. New Markets comprise Appen's data annotation platform and tools (Global Product), and the enterprise, government, and China business units. New Markets also include Quadrant geolocation and Point-of-Interest (POI) data capabilities. Its Annotation Platform is the platform that both customers and internal teams used to design, run and manage data annotation tasks. The firm serves various industries, including technology, automotive, financial services, healthcare, retail, and government agencies.
🙌 Performance (5Yr p.a)
-18.08%
📊 Share price
$2.05 AUD
🤖 TECHNOLOGY
BBOZ.AX was created on 2015-04-17 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to help investors profit from, or protect against, a declining Australian share market. It seeks to generate magnified returns that are negatively correlated to the returns of the Australian share market (as measured by the S&P/ASX 200 Index)
🙌 Performance (5Yr p.a)
34.32%
📊 Share price
$26.70 AUD
📈 HIGH PRICE GROWTH
📞 COMMUNICATIONS
Want more shares? Try these...
ADS
Adslot Ltd. engages in the provision of trading technology and services solutions. The company is headquartered in Melbourne, Victoria. Its principal activities include Trading Technology and Services. Trading Technology comprises Adslot Media, a global media trading technology platform, and Symphony, a workflow automation technology for media agencies. Services comprise digital marketing services provided by the Company's Webfirm division and project-based customization of Trading Technology. Adslot Media is an independent programmatic guaranteed technology that scales publisher-direct media buying through a direct connection with publisher ad servers. Symphony is the buying and planning workflow platform for media agencies. Symphony manages every step of the media buying life cycle. Adslot and Symphony provides end-to-end media planning, buying, and selling management for the advertising industry. The company operates in North America, Europe, and Asia Pacific.
🙌 Performance (5Yr p.a)
-19.23%
📊 Share price
$0.00 AUD
🤖 TECHNOLOGY
Adriatic Metals PLC is a GB-based company operating in Metals & Mining industry. The company is headquartered in Cheltenham, Gloucestershire and currently employs 296 full-time employees. The company went IPO on 2018-05-01. Adriatic Metals PLC is a United Kingdom-based precious and base metals mining company that is advancing the Vares Silver Operation in Bosnia and Herzegovina, as well as the Raska Zinc-Silver Project in Serbia. The firm's flagship Vares Project is located approximately 50 kilometers (km) north of Sarajevo, in the district of Vares. The company owns 100% of the 44 square kilometers (km2) Vares Project concession. The concession area includes the mineralization included in the Mineral Resource Estimates of Rupice and Veovaca, as well as a number of prospects and exploration targets. The polymetallic underground deposit of Rupice has high grades of silver and zinc, with lead, copper and gold credits. The Raska Zinc-Silver Project is a prospective 130 km2 land package in southern Serbia, focused primarily around two historic open pit mining operations: Sastavci and Kizevak deposits that sit on the polymetallic tethyan metallogenic belt, which contain zinc, silver and lead mineralization.
🙌 Performance (5Yr p.a)
60.77%
📊 Share price
$4.22 AUD
⛏️ MINING
AnteoTech Ltd. engages in the development, manufacturing, and distribution of life sciences, clinical diagnostics and bio-separations products and services. The company is headquartered in Eight Mile Plains, Queensland. The company went IPO on 2000-04-11. The principal activities of the Company consist of development and commercialization of nanotechnologies with surface management applications. The Company’s lead product, Anteo X, provides significant improvement in anode performance and the Company partners with global suppliers in lithium-ion battery manufacturing. Its clean energy technology (CET) technologies improve the energy densities, cycle life and cost- effectiveness of lithium-ion batteries. The firm has two programs underway: Anteo X, its binder additive and the High Silicon Anode technology. The Life Sciences division services the point-of-care and in vitro diagnostics markets from global diagnostics companies to technology developers. Its AnteoBind provides advantages in bioconjugation to rapidly speed up testing procedures and improve accuracy.
🙌 Performance (5Yr p.a)
22.42%
📊 Share price
$0.03 AUD
🧪 CHEMICALS
📈 HIGH PRICE GROWTH